SCHEMBL27558484

SCHEMBL27558484

CCCCC(C)CCC(C)CCCC

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.52
LMNA P02545 2/20 0.47
DNM1 Q05193 2/20 0.45
OPRM1 P35372 1/20 0.43
TSHR P16473 5/20 0.40
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CYP3A4 P08684 1/20 0.38
THRB P10828 1/20 0.38
FDPS P14324 1/20 0.38
MAPT P10636 1/20 0.36
CA2 P00918 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31342702 0.97 ACE2 (0.56) ACE2LMNADNM1OPRM1TSHR
SCHEMBL56652 0.96 LMNA (0.50) ACE2LMNADNM1OPRM1TSHR
SCHEMBL30708135 0.94 ACE2 (0.60) ACE2LMNADNM1OPRM1TSHR
SCHEMBL1357448 0.94 ACE2 (0.48) ACE2LMNADNM1OPRM1TSHR
SCHEMBL31521551 0.93 LMNA (0.56) ACE2LMNADNM1OPRM1TSHR
Ammonia Solution, Strong SCHEMBL524060 0.93 LMNA (0.47) ACE2LMNADNM1OPRM1TSHR
SCHEMBL9650202 0.91 ACE2 (0.46) ACE2LMNADNM1OPRM1TSHR
SCHEMBL9438278 0.91 LMNA (0.55) ACE2LMNADNM1OPRM1TSHR
SCHEMBL31521553 0.91 ACE2 (0.64) ACE2LMNADNM1OPRM1TSHR
Water SCHEMBL27672289 0.91 ACE2 (0.58) ACE2LMNADNM1OPRM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070352-A Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof 切弗朗菲利浦化学公司 2026-05-19 CN disclosed
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-04-16 US disclosed
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-03 US disclosed
WO-2025054258-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-03-13 WO disclosed
US-20250084331-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-03-13 US disclosed
EP-3795561-B1 METHOD FOR PRODUCING CARBAMATE AND METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2024-11-06 EP disclosed
US-11352319-B2 Method for producing carbamate and method for producing isocyanate ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-06-07 US disclosed
CN-1295075-A Metal organic compound and polymer therefrom ELF ATECHOM NORTH AMERICA INC (US) 2001-05-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352319-B2 Method for producing carbamate and method for producing isocyanate CPS1, CA7, CA4 ACE2 2252/4885LMNA 2202/4885DNM1 1779/4885
US-20250084331-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME ECH1, YAP1, ECHS1 ACE2 1588/4885LMNA 1124/4885DNM1 2298/4885
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME YAP1, CYP4F8, SCD ACE2 3814/4885LMNA 2968/4885DNM1 2138/4885
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same ADH1A, ADH1C, YAP1 ACE2 1833/4885LMNA 2460/4885DNM1 1541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.